eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
vol. 124
Poleć ten artykuł:
streszczenie artykułu:
Opis przypadku

Observation of changes in the eye and joints due to the modification of therapy for ankylosing spondylitis and recurrent uveitis – a twenty-year follow-up study

Bernadetta Płatkowska-Adamska
1, 2
Magdalena Kal
1, 2
Ewa Pater
Maria Maciejowska-Roge
Jan Biskup
Michał Biskup
Dominik Odrobina
1, 4

Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Ophthalmology Clinic, Voivodeship Hospital, Kielce, Poland
Division of Rheumatology, Health Care Centre, Wloszczowa, Poland
Ophthalmology Clinic, St. John Boni Fratres Lodziensis, Lodz, Poland
KLINIKA OCZNA 2022, 124, 4: 245-248
Data publikacji online: 2022/12/19
Pełna treść artykułu Pobierz cytowanie
Metryki PlumX:

We present a twenty-year follow-up study of a patient and changes in his eyes and joints under various therapies for ankylosing spondylitis. Sulfasalazine, methotrexate, etanercept and adalimumab were used to treat the systemic disease. Ophthalmological treatment of recurrent uveitis occurring every 2 months included intravenous dexamethasone, oral prednisone and topical dexamethasone and 1% tropicamide. Long-term treatment with steroids resulted in complications such as cataracts and herpetic keratitis. Prior to treatment with adalimumab, treatment-resistant, recurrent uveitis and complications such as proliferative vitreoretinopathy and secondary retinal detachment resulted in irreversible lesions and blindness in the right eye. By switching the TNF-α inhibitor to adalimumab for rheumatological ailments, the patient achieved significant improvement in visual acuity in the left eye and a long-term absence of inflammatory symptoms in this eye, which confirms that in the case of spondyloarthropathy, the cooperation of a rheumatologist and an ophthalmologist is necessary.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.